Selskabets formål er at drive virksomhed med udvikling og markedsføring af nye metoder til bioteknologisk diagnosticering samt anden hermed forbunden virksomhed.
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | - | 7.6 mio. | 10.5 mio. | 10.5 mio. | - | |
CVR: 27585167
Secondary names: QUANTIBACT A/S
Previous names: LNA BACTERIAL DETECTION A/S, QUANTIBACT A/S
Caroline Marie Morgenthaler Echwald joined the board
Anne Margrethe Echwald left the board
Companies in the same industry and area
companydata.dk